Rice Hall James & Associates LLC reduced its position in shares of HealthSouth Corp. (NYSE:HLS) by 1.1% during the second quarter, according to its most recent filing with the SEC. The institutional investor owned 434,318 shares of the company’s stock after selling 4,762 shares during the period. Rice Hall James & Associates LLC’s holdings in HealthSouth Corp. were worth $16,860,000 as of its most recent filing with the SEC.
Several other hedge funds have also recently added to or reduced their stakes in the stock. Acrospire Investment Management LLC bought a new stake in HealthSouth Corp. during the first quarter worth approximately $105,000. Creative Planning boosted its stake in HealthSouth Corp. by 2.0% in the second quarter. Creative Planning now owns 2,858 shares of the company’s stock worth $111,000 after buying an additional 56 shares during the period. BNP Paribas Arbitrage SA boosted its stake in HealthSouth Corp. by 7,088.4% in the second quarter. BNP Paribas Arbitrage SA now owns 4,960 shares of the company’s stock worth $193,000 after buying an additional 4,891 shares during the period. Bayesian Capital Management LP bought a new stake in HealthSouth Corp. during the first quarter worth approximately $259,000. Finally, Massmutual Trust Co. FSB ADV bought a new stake in HealthSouth Corp. during the first quarter worth approximately $270,000. Institutional investors and hedge funds own 94.94% of the company’s stock.
HealthSouth Corp. (NYSE:HLS) traded down 0.67% during trading on Monday, hitting $40.30. 486,661 shares of the stock traded hands. HealthSouth Corp. has a 12 month low of $30.26 and a 12 month high of $43.38. The stock has a market cap of $3.62 billion, a P/E ratio of 17.69 and a beta of 1.02. The firm’s 50-day moving average is $40.73 and its 200-day moving average is $39.68.
HealthSouth Corp. (NYSE:HLS) last announced its quarterly earnings results on Thursday, July 28th. The company reported $0.69 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.60 by $0.09. The company had revenue of $920.70 million for the quarter, compared to analyst estimates of $906.67 million. HealthSouth Corp. had a net margin of 6.26% and a return on equity of 28.99%. The firm’s revenue was up 20.4% on a year-over-year basis. During the same period in the prior year, the firm posted $0.47 earnings per share. On average, analysts forecast that HealthSouth Corp. will post $2.52 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Monday, October 17th. Shareholders of record on Monday, October 3rd will be paid a $0.24 dividend. This is a positive change from HealthSouth Corp.’s previous quarterly dividend of $0.23. This represents a $0.96 annualized dividend and a yield of 2.38%. The ex-dividend date of this dividend is Thursday, September 29th. HealthSouth Corp.’s dividend payout ratio is currently 42.29%.
A number of analysts recently commented on HLS shares. Barclays PLC cut shares of HealthSouth Corp. from an “equal weight” rating to an “underweight” rating and lowered their target price for the stock from $45.00 to $42.00 in a research note on Monday, June 27th. They noted that the move was a valuation call. Wells Fargo & Co. restated a “buy” rating on shares of HealthSouth Corp. in a research note on Sunday, September 11th. Zacks Investment Research upgraded shares of HealthSouth Corp. from a “hold” rating to a “buy” rating and set a $47.00 price objective for the company in a research note on Monday, August 1st. SunTrust Banks Inc. set a $54.00 price objective on shares of HealthSouth Corp. and gave the company a “buy” rating in a research note on Monday, August 1st. Finally, JMP Securities restated a “buy” rating on shares of HealthSouth Corp. in a research note on Sunday, September 4th. One analyst has rated the stock with a sell rating, three have issued a hold rating and seven have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $46.00.
In other HealthSouth Corp. news, COO Mark J. Tarr sold 20,000 shares of the stock in a transaction that occurred on Tuesday, August 2nd. The shares were sold at an average price of $41.85, for a total value of $837,000.00. Following the transaction, the chief operating officer now directly owns 252,519 shares in the company, valued at $10,567,920.15. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 5.00% of the stock is currently owned by company insiders.
HealthSouth Corp. Company Profile
HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in over 30 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company’s segments include inpatient rehabilitation, and home health and hospice.
Want to see what other hedge funds are holding HLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthSouth Corp. (NYSE:HLS).
Receive News & Ratings for HealthSouth Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corp. and related companies with MarketBeat.com's FREE daily email newsletter.